AMRX FY 2017 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B+1.5% YoY

Gross Profit

$526M50.9% margin

Operating Income

$245M23.7% margin

Net Income

$168M16.2% margin

EPS (Diluted)

$1.46

Cash Flow

Operating Cash Flow

$234M

Free Cash Flow

$120M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.7B

Stockholders' Equity

-$386M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$1.0B	+1.5%
Gross Profit	$526M	$597M	-11.9%
Operating Income	$245M	$285M	-14.0%
Net Income	$168M	$207M	-19.2%